Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
146 studies found for:    Open Studies | "Pharyngeal Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Pharyngeal Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Laryngeal Mask Airway Removal During Deep Anesthesia in Children
Condition: Post Operative Sore Throat After LMA Removal
Intervention: Other: LMA removal
2 Recruiting Study Evaluating Two Loading Regimens of Sunitinib Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: 12.5mg sunitinib with Cisplatin and Gemcitabine;   Drug: 25mg Sunitinib alternating with Cisplatin and Gemcitabine
3 Unknown  Optimal Management of Malignant Dysphagia
Conditions: Malignant Dysphagia;   Esophageal Cancer
Interventions: Radiation: Brachytherapy;   Procedure: Stent insertion
4 Unknown  Impact of Blades Used for Scheduled Orotracheal Intubation on Postoperative Sore Throat
Conditions: Tracheal Intubation Morbidity;   Sore Throat
Interventions: Device: metal reusable blades MacIntosh;   Device: Single use plastic blades HEINE XP®
5 Unknown  Effect of Afferent Oropharyngeal Pharmacological and Electrical Stimulation on Swallow Response and on Activation of Human Cortex in Stroke Patients With Oropharyngeal Dysphagia
Conditions: Dysphagia,;   Aspiration,;   Swallow Response,;   Videofluoroscopy,;   Sensorial Neurostimulation.
Interventions: Behavioral: Dietary and oral hygiene recommendations;   Dietary Supplement: oral TRPV1 agonist;   Device: pharyngeal electrical stimulation;   Device: transcutaneous electrical stimulation
6 Unknown  Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: cisplatin;   Radiation: 3D-CRT (three-dimensional conformal radiation therapy) or IMRT (intensity-modulated radiation therapy)
7 Recruiting A Phase I/II to Assess Safety, Tolerability and Efficacy of DL-lactic Acid Syrup in Children With Recurrent Tonsillitis
Condition: Recurrent Tonsillitis in Children
Interventions: Drug: DL - Lactic Acid;   Dietary Supplement: Raspberry flavored syrup
8 Recruiting Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer
Conditions: 1、Enough Cases;   2、Elekta Precise 1343 Digital Control Electron Linear Accelerator;   Can Undertake Nasopharyngeal Carcinoma Specimens in the Materia,;   Image Department of Nose Pharynx Ministry MRI Dynamic Testing,
Intervention: Drug: Recombine Endostatin
9 Recruiting Functional Endoscopy in Neurogenic Dysphagia
Condition: Neurogenic Dysphagia
Intervention: Procedure: transnasal functional endoscopy
10 Recruiting Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis
Conditions: Nasopharyngeal Carcinoma;   Radiation Therapy Complication
Interventions: Drug: Atorvastatin;   Other: Placebo
11 Recruiting Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Conditions: Salivary Gland Squamous Cell Carcinoma;   Stage II Salivary Gland Cancer;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Squamous Cell Carcinoma of the Oropharynx;   Stage II Verrucous Carcinoma of the Oral Cavity;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Verrucous Carcinoma of the Oral Cavity
Interventions: Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Radiation: image-guided adaptive radiation therapy;   Other: 3'-deoxy-3'-[18F]fluorothymidine;   Procedure: positron emission tomography/computed tomography;   Radiation: fludeoxyglucose F 18
12 Unknown  Clinical Evaluation of Swallowing Disorders as a Predictor of Extubation Failure
Conditions: Central Nervous System Diseases;   Acute Respiratory Failure;   Shock;   Heart Failure;   Acute Poisoning
Intervention: Procedure: extubation
13 Recruiting Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer
Conditions: Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Radiation: Intensity-Modulated Radiation Therapy (IMRT);   Drug: cisplatin;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
14 Unknown  Assessing the Necessity of Prescribing Antibiotics (Clavulin or Clindamycin Versus Placebo) Post-peritonsillar Abscess Drainage
Condition: Peritonsillar Abscess
Interventions: Drug: Clavulin;   Drug: Randomization to Placebo;   Drug: Clindamycin
15 Recruiting TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
Condition: EBV-positive Nasopharyngeal Carcinoma
Intervention: Genetic: DNR.NPC-specific T cells
16 Recruiting Phase Ⅲ Study of Neoadjuvant TPF Chemotherapy Followed by Radiotherapy and Concurrent Nimotuzumab or Cisplatin for Locoregionally Advanced Nasopharyngeal Carcinoma (NPC).
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: TPF neoadjuvant chemotherapy;   Drug: Concurrent chemotherapy with cisplatin during radiotherapy;   Drug: Concurrent nimotuzumab during radiotherapy;   Radiation: Radical radiotherapy
17 Recruiting Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: gemcitabine and cisplatin (Induction chemotherapy);   Radiation: IMRT and concurrent cisplatin
18 Recruiting Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Carcinoma
Interventions: Dietary Supplement: nitrate supplementation;   Dietary Supplement: Placebo
19 Recruiting Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Capecitabine;   Drug: Adjuvant chemotherapy using PF (5-Fluorouracil );   Drug: Induction chemotherapy using PF (5-Fluorouracil)
20 Recruiting Comparison of the Effect of Magnesium Sulfate and Dexamethasone on Postoperative Sore Throat After Spinal Surgery in Prone Position With Tracheal Intubation: a Double-blind, Randomized, Noninferiority Clinical Trial
Condition: Post Operative Sore Throat
Interventions: Drug: Magnesium Sulfate;   Drug: dexamethasone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years